期刊文献+

精神分裂症患者药物治疗过程中血糖三酰甘油和甲状腺素水平分析 被引量:1

Analysis on the levels of blood glucose,triglyceride and serum thyroid hormone in patients with schizophrenia
下载PDF
导出
摘要 目的比较精神分裂症患者服用抗精神病药物后血葡萄糖(glucose,GLU)、甘油三酰(triglyceride,TG)和游离三碘甲状腺原氨酸(fee-triio-dothyronine,FT3)、游离甲状腺素(free-thyroxine, FT4)、促甲状腺素(thyroidstimulathing hormone,TSH)水平的变化。方法观察不同抗精神病药物治疗的患者88例,分别于第2、4、8、12周检测血GLU、TG和甲状腺素水平。结果在治疗过程中,两组患者血GLU水平略有升高,但差异无统计学意义(P>0.05)。治疗4周后,TG水平都显著升高,氯氮平组差异有统计学意义(P<0.01),利培酮组差异也有统计学意义(P<0.05)。在治疗8周后,氯氮平组TG水平进一步升高(P<0.001),利培酮组TG水平也明显升高(P<0.01),此时两组FT_4水平都显著降低(P<0.05),而TSH水平却显著升高(P<0.05),且患者TG与FT_3、FT_4水平呈显著负相关。结论长期服用氯氮平和利培酮治疗的精神分裂症患者存在脂代谢紊乱,而这种紊乱与甲状腺素水平有显著的相关性。 Objective To confer the leves of blood glucose(GLU) and triglyceride (TG) and serum thyroid hormone in patients with schizophrenia in the cause of treatment. Methods To survey 88 patients with schizophrenia,and assess sera concentration of GLU and TG and thyroid hormone before treatment and during week 2,week 4,week 8,week 12. Results In the cause of treatments, the levels of GLU were up regulated slightly(P〉0.05). The levels of TG rose obviously in the elozapine group (P〈0.01) and the risperidone group (P〈0.05). Afer the treatment of week 8,the levels of TG were up regulated in the elozapine group(P〈0.01) and the risperidone group (P〈0.01) ,the level of freethyroxine( FT4 ) were down-regulated (P 〈 0. 05 ), while the level of thyroid stimulathing hormone (TSH) were up-regulated(P〈0.05). As well as,there were a correlation between the levels of TG and free triioothyronine(FT3), (FT4). Conclusion The glycometabolism and lipid metabolism were disturbance in patients with schizophrenia treated with clozapine or risperidone,which were related to the of serum thyroid hormone.
出处 《国际检验医学杂志》 CAS 2008年第12期1099-1100,1103,共3页 International Journal of Laboratory Medicine
关键词 精神分裂症 血糖 甘油三酯类 甲状腺素 Schizophrenia Blood Glucose Triglycerides Thyroxine
  • 相关文献

参考文献6

  • 1Melkersson K,Dahl ML. Adverse metabolic effect associated with atypical antipsychotics :literarure review and clinical implications [J]. Drugs, 2004,64(7) : 701-723.
  • 2Sim K, Chong SA, Chan YH, et al. Thyroid dysfunction in chronic schizophrenia within a psychiatric hospital[J]. Ann Acad Med Singapore, 2002,31 (5) : 641-644.
  • 3Nasrallah HA. Factors in antipsychotic drug selection: tolerability considerations[J]. CNS Spectr, 2003,8(11 ) : 23-25.
  • 4Paunovic VR,Timotijevic I, Marinkovic D. Neuroleptic actions on the thyroidaxis:different effects of clozapine and haloperidol[J]. Int Clin Psychopharmacol, 1991,6(3) :133-139.
  • 5Ramscha K Schwarzer S,Radkohi W, Stiegler C, et al. Interaction between psychctriopic drugs and thyroid hormone metabolisman. Overview [J]. Acta Med Austriaca, 2000,27: 8-10.
  • 6李建薇,田浩明.内分泌疾病的脂代谢异常[J].临床内科杂志,2003,20(3):113-115. 被引量:6

二级参考文献22

  • 1[1]Bakker O, Hudig F, Meijssen S, et al. Effects of triiodothyronine and amiodarone on the promoter of the human LDL receptor gene.Biochem Biophys Res Commun,1998,249:517-521.
  • 2[2]Riis AL, Gravholt CH, Djurhuus CB, et al. Elevated regional lipolysis in hyperthyroidism. J Clin Endocrinol Metab,2002,87:4747-453.
  • 3[3]Sundaram V, Hanna AN, Koneru L, et al. Both hypothyroidism and hyperthyroidism enhance low density lipoprotein oxidation. J Clin Endocrinol Metab,1997,82:3421-3424.
  • 4[4]Lekakis J, Papamichael C, Alevizaki M, et al. Flow-mediated, endothelium-dependent vasodilation is impaired in subjects with hypothyroidism, borderline hypothyroidism, and high-normal serum thyrotropin (TSH) values. Thyroid,1997,7:411-414.
  • 5[5]Mya MM, Aronow WS. Subclinical hypothyroidism is associated with coronary artery disease in older persons. J Gerontol A Biol Sci Med Sci,2002,57:658-659.
  • 6[6]The Expert Panel. Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Arch Intern Med,1988,148:36-39.
  • 7[7]Vanderpump MP, Tunbridge WM, French JM, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf),1995,43:55-68.
  • 8[8]Deschampheleire M, Luyckx FH, Scheen AJ. Thyroid disorders and dyslipidemias. Rev Med Liege,1999,54:746-750.
  • 9[9]Bauer DC, Ettinger B, Browner WS. Thyroid functions and serum lipids in older women: a population-based study. Am J Med,1998,104:546-551.
  • 10[10]Terzolo M, Pia A, Ali A, et al. Adrenal incidentaloma: a new cause of the metabolic syndrome? J Clin Endocrinol Metab,2002,87:998-1003.

共引文献5

同被引文献4

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部